+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

In-vitro susceptibility to LY333328 of vancomycin-resistant enterococci isolated from humans and animals



In-vitro susceptibility to LY333328 of vancomycin-resistant enterococci isolated from humans and animals



Journal of Antimicrobial ChemoTherapy 40(5): 733-734




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 046368136

Download citation: RISBibTeXText

PMID: 9421326


Related references

In-vitro susceptibility to Ly333328 of vancomycin-resistant enterococci isolated from humans and animals. Journal of Antimicrobial Chemotherapy 40(5): 733-734, 1997

In vitro activity of LY333328 against vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus, and penicillin-resistant Streptococcus pneumoniae. Diagnostic Microbiology and Infectious Disease 30(2): 89-92,., 1998

The in-vitro activity of LY333328, a new glycopeptide, against clinical isolates of vancomycin-resistant enterococci. Advances in Experimental Medicine and Biology 418: 483-485, 1997

In vitro activity of LY333328, a new glycopeptide, against extracellular and intracellular vancomycin-resistant enterococci. Infection 28(4): 214-218, 2000

Characterization of vanA vancomycin-resistant enterococci isolated from humans and animals in Taiwan. Abstracts of the General Meeting of the American Society for Microbiology 103: C-412, 2003

Prevalence and molecular epidemiology of vancomycin-resistant enterococci (VRE) strains isolated from animals and humans in Korea. Korean Journal of Internal Medicine 20(1): 55-62, 2005

Comparative in vitro activity and inoculum effect of LY333328 against vancomycin resistant and susceptible enterococci isolates obtained from ICU patients. Abstracts of the Interscience Conference on Antimicrobial Agents and Chemotherapy 37: 146, 1997

Antimicrobial susceptibility of vancomycin-susceptible and -resistant enterococci isolated in Italy from raw meat products, farm animals, and human infections. International Journal of Food Microbiology 97(1): 17-22, 2004

Antibiotic activity against urinary tract infection (UTI) isolates of vancomycin-resistant enterococci (VRE): results from the 2002 North American Vancomycin Resistant Enterococci Susceptibility Study (NAVRESS). Journal of Antimicrobial ChemoTherapy 52(3): 382-388, 2003

Non-clinical pharmacokinetics of LY333328, a semisynthetic glycopeptide antibiotic active against vancomycin-resistant Enterococci. Abstracts of the Interscience Conference on Antimicrobial Agents and Chemotherapy 35: 157, 1995

Establishment of neutropenic mouse model to characterize activity of LY333328 against vancomycin-resistant enterococci. Abstracts of the Interscience Conference on Antimicrobial Agents and Chemotherapy 37: 148, 1997

Comparison of antimicrobial susceptibility of vancomycin resistant enterococci from animals and human. Korean Journal of Veterinary Public Health 27(1): 17-29, 2003

Vancomycin-resistant enterococci - the nature of resistance and risk of transmission from animals to humans. Klinicka Mikrobiologie a Infekcni Lekarstvi 22(2): 54-60, 2016

Vancomycin-resistant enterococci isolated from animals and food. International Journal of Food Microbiology 54(3): 197-204, 2000

Development of a process for production of LY333328, a semisynthetic glycopeptide antibiotic active against vancomycin resistant enterococci. Abstracts of Papers American Chemical Society 215(1-2): ORGN 241, 1998